Back to News
Market Impact: 0.6

Signet Jewelers Lifts 2026 Outlook

SIGNDAQ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsTax & TariffsCommodities & Raw MaterialsCapital Returns (Dividends / Buybacks)Consumer Demand & RetailInflation
Signet Jewelers Lifts 2026 Outlook

Signet Jewelers reported strong Q2 FY26 results, with revenue exceeding $1.5 billion, 2% comparable sales growth, and adjusted EPS up 29% to $1.61, largely due to successful execution of its brand-focused strategy, including 5% comp growth in core banners and doubled lab-grown diamond sales. The company also achieved a 60 basis point gross margin expansion and over 20% adjusted operating income growth despite significant gold cost increases and higher India import tariffs, demonstrating robust operational discipline. This strong performance, coupled with a healthy balance sheet and $150 million in share repurchases, led management to raise full-year sales and EPS guidance, underscoring Signet's resilience and strategic effectiveness in a challenging retail environment.

Analysis

Signet Jewelers (SIG) delivered a strong second-quarter fiscal 2026 performance, beating expectations with revenue over $1.5 billion, a 2% increase in same-store sales, and a 29% year-over-year rise in adjusted EPS to $1.61. The results were driven by the successful execution of its brand-focused strategy, evidenced by back-to-back quarters of approximately 5% comparable sales growth in its three core banners—Kay, Zales, and Jared—which materially outpaced the company's overall growth. This strategic focus is further validated by rapid consumer adoption of lab-grown diamonds, which now constitute 14% of fashion sales, double the penetration from the prior year. Significantly, Signet demonstrated impressive operational resilience by expanding its gross margin rate by 60 basis points, despite substantial headwinds from a 30% surge in gold costs and a punitive increase in India import tariffs from 10% to 50% on a large portion of its merchandise. This margin strength, coupled with SG&A discipline, fueled over 20% growth in adjusted operating income. The company’s financial health is underscored by prudent inventory management, which held levels flat despite cost inflation, robust liquidity of $1.4 billion, and a commitment to capital returns, with $150 million in shares repurchased year-to-date. Consequently, management raised its full-year guidance for sales, operating income, and EPS, although it noted that achieving the upper end of the EPS range ($8.04-$9.57) is contingent on the removal of the aforementioned tariff risks.